Associate Professor James Fullerton has been awarded Fellowship of the British Pharmacological Society (BPS) following a recommendation by their Honors and Fellows Panel, recognising his sustained contribution to the discipline of Clinical Pharmacology and Therapeutics.
Paul joined the Kennedy Institute in September 2024 as part of the Newton-Abraham Visiting Professorship, a prestigious award given by the University of Oxford to the most distinguished scholars in the biological, chemical or medical sciences.
A new study has revealed that machine learning models can significantly outperform experienced surgeons in predicting patient outcomes after partial knee replacement.
The first human tissue samples from Oxford's Space Innovation Lab (SIL) have been launched and are on their way to the International Space Station, where they will be used to study the effects of space microgravity on the human ageing process.
The NIHR Oxford Clinical Research Facility (EMCRF) has expanded its support of medical research trials by offering bone marrow biopsies for the first time.
NDORMS is pleased to announce the appointment of Sarah Snelling and Antony Palmer as the new co-Directors of the two-year, part-time MSc in Musculoskeletal Sciences.
Patients hospitalised with COVID-19 often report a wide range of symptoms months after their initial illness. But a new study from NDORMS shows that post-acute infection syndrome (PAIS) is not unique to COVID-19 and can also occur after other respiratory infections.
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
The MSc in Experimental and Translational Therapeutics (ETT) is moving to NDORMS. Jointly run with the Department of Continuing Education, the move will expand the already broad range of disciplines covered in the course.
To mark World Arthritis Day, the British Society for Rheumatology has announced the launch of a new toolkit that will help patients take more control of their arthritis treatment.
NDORMS researchers have received funding from the Medical Research Council (MRC) to explore a new treatment for anterior cruciate ligament (ACL) injuries which could provide relief for thousands of young people suffering from knee pain.
Dr Kate Coldwell has joined the Oxford Centre for Microbiome Studies at the Kennedy Institute to study the links between liver disease and gut bacteria, having been awarded the Daphne Jackson Fellowship, co-funded by the Kennedy Trust for Rheumatology Research (KTRR) and the Medical Research Council.
Professor Sir Ravinder Maini and Professor Sir Marc Feldmann have jointly received The Royal Society\u2019s Royal Medal (Applied) for inventing anti-TNF therapy to treat rheumatoid arthritis (RA), bringing it from bench to bedside in one of the biggest success stories of modern medicine.
Tal Arnon, Stephanie Dakin and Catherine Swales have each been awarded title of \u2018Full Professor\u2019 in the University of Oxford's 2024 Recognition of Distinction exercise.
\u00a328.5m in funding has been announced to support functional genomics research across the UK, including a research cluster at NDORMS that will deliver insights into musculoskeletal health and disease.
A new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between researchers from the University of Oxford, University of Bristol, and University of Copenhagen. The model could be an important tool to help both patients and doctors make more informed decisions about this common procedure.
![\"\"](\"https://www.ndorms.ox.ac.uk/news/james-fullerton-awarded-a-british-pharmacological-society-fellowship/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n